Corporate & Investor Presentation
Digital health solutions for inhaled COPD pharmaceuticals
●
ResMed now has end-to-end solutions for Digital Health for
COPD patients across stages I, II, III, IV of the disease
Uses sensors with inhalers to track medication usage and
provide personal feedback and insights
UPSTREAM
Customers include:
$$
Patients$$
●
Establishes ResMed as a leading provider of COPD and
asthma patient management solutions
Enables digitally-enabled integration of care through the
progression of the disease
Health and economic
outcomes
Payers
DOWNSTREAM
Anthem
gsk
✓
Boehringer
Ingelheim
ORION
NOVARTIS
Increased drug
adherence and sales
Pharma companies signed
represent 90% of long-acting
respiratory inhalation drugs
Improved clinical trial
speed and enhanced time
to market
47 2020 ResMed | Corporate & Investor Presentation - updated 05AUG20
PBMS
EXPRESS SCRIPTS
Propeller
Clinical insights and
efficiencies
Health
systems
Dignity Health.
($$
Patients + $$
Pharmacies
Walgreens
Patient Acquisition
ResMedView entire presentation